[ad_1] Hi, MarketWatchers. Don’t miss these top stories. Americans give U.S. health-care system a dismal…
Healthcare/Life Sciences
-
-
[ad_1] The stock market had two strong rally days this week. That was mostly because…
-
STOCK MARKET
21 dividend stocks yielding 5% or more of companies that will produce plenty of cash in 2023
by userby user[ad_1] When the stock market has jumped two days in a row, as it has…
-
STOCK MARKET
Here’s one thing that will cost less next year—what it means for Medicare beneficiaries
by userby user[ad_1] This article is reprinted by permission from NerdWallet. While inflation is pushing up prices…
-
STOCK MARKET
Here’s why one strategist says the consumer and related stocks might get a second wind
by userby user[ad_1] Welcome to intervention Wednesday. The Bank of England has halted, at least for now,…
-
STOCK MARKET
Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
by userby user[ad_1] Eisai Co. shares were indicated sharply higher Wednesday morning after the Japanese drug maker…
-
[ad_1] Eisai Co. 4523, +0.89% and Biogen Inc. BIIB, +1.04% said their experimental Alzheimer’s disease drug significantly slowed progression of…
-
STOCK MARKET
Feeding people on this warming Earth requires future-proofing our agri-food systems. Here’s how.
by userby user[ad_1] These days, it is easy to feel overwhelmed. A worsening regional conflict in Ukraine, overlain onto…
-
[ad_1] What the actual cluck? The latest seriously questionable social-media trend apparently has people sautéing…
-
[ad_1] Roche Holding AG said Monday that its vision-loss treatment Vabysmo has been approved in…